| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 5.39e-15 | 5 | 30 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 3.23e-14 | 6 | 30 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | chloride ion binding | 2.33e-11 | 16 | 30 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 4.26e-07 | 103 | 30 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 2.24e-06 | 144 | 30 | 5 | GO:0016798 | |
| GeneOntologyMolecularFunction | calcium ion binding | 9.72e-05 | 749 | 30 | 7 | GO:0005509 | |
| GeneOntologyMolecularFunction | phosphatidylinositol transfer activity | 1.19e-04 | 11 | 30 | 2 | GO:0008526 | |
| GeneOntologyMolecularFunction | 5S rRNA binding | 1.96e-04 | 14 | 30 | 2 | GO:0008097 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 4.08e-04 | 20 | 30 | 2 | GO:0008525 | |
| GeneOntologyMolecularFunction | phospholipid transfer activity | 6.93e-04 | 26 | 30 | 2 | GO:0120014 | |
| GeneOntologyMolecularFunction | phosphatidylcholine binding | 1.19e-03 | 34 | 30 | 2 | GO:0031210 | |
| GeneOntologyMolecularFunction | quaternary ammonium group binding | 2.17e-03 | 46 | 30 | 2 | GO:0050997 | |
| GeneOntologyMolecularFunction | lipid transfer activity | 3.31e-03 | 57 | 30 | 2 | GO:0120013 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 5.51e-03 | 74 | 30 | 2 | GO:0005548 | |
| GeneOntologyMolecularFunction | rRNA binding | 6.26e-03 | 79 | 30 | 2 | GO:0019843 | |
| GeneOntologyMolecularFunction | receptor tyrosine kinase binding | 8.05e-03 | 90 | 30 | 2 | GO:0030971 | |
| Domain | Aamy_C | 4.69e-12 | 4 | 29 | 4 | SM00632 | |
| Domain | Alpha_amylase | 4.69e-12 | 4 | 29 | 4 | IPR006046 | |
| Domain | Alpha-amylase_C | 2.34e-11 | 5 | 29 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 2.34e-11 | 5 | 29 | 4 | IPR006048 | |
| Domain | Aamy | 1.63e-10 | 7 | 29 | 4 | SM00642 | |
| Domain | Alpha-amylase | 1.63e-10 | 7 | 29 | 4 | PF00128 | |
| Domain | Glyco_hydro_13_cat_dom | 1.63e-10 | 7 | 29 | 4 | IPR006047 | |
| Domain | A-amylase_C | 3.37e-09 | 3 | 29 | 3 | IPR031319 | |
| Domain | Glyco_hydro_b | 6.32e-09 | 15 | 29 | 4 | IPR013780 | |
| Domain | Glyco_hydro_13 | 6.71e-08 | 6 | 29 | 3 | IPR015902 | |
| Domain | Glyco_hydro_catalytic_dom | 3.34e-07 | 38 | 29 | 4 | IPR013781 | |
| Domain | - | 1.21e-06 | 14 | 29 | 3 | 2.60.40.1180 | |
| Domain | Glycoside_hydrolase_SF | 1.30e-06 | 53 | 29 | 4 | IPR017853 | |
| Domain | - | 2.13e-05 | 35 | 29 | 3 | 3.20.20.80 | |
| Domain | IP_trans | 2.32e-05 | 5 | 29 | 2 | PF02121 | |
| Domain | LNS2 | 3.48e-05 | 6 | 29 | 2 | PF08235 | |
| Domain | DDHD_dom | 3.48e-05 | 6 | 29 | 2 | IPR004177 | |
| Domain | LNS2 | 3.48e-05 | 6 | 29 | 2 | IPR013209 | |
| Domain | PI_transfer | 3.48e-05 | 6 | 29 | 2 | IPR001666 | |
| Domain | LNS2 | 3.48e-05 | 6 | 29 | 2 | SM00775 | |
| Domain | DDHD | 3.48e-05 | 6 | 29 | 2 | SM01127 | |
| Domain | DDHD | 3.48e-05 | 6 | 29 | 2 | PF02862 | |
| Domain | DDHD | 3.48e-05 | 6 | 29 | 2 | PS51043 | |
| Domain | LNS2/PITP | 3.48e-05 | 6 | 29 | 2 | IPR031315 | |
| Domain | Znf_SWIM | 8.32e-05 | 9 | 29 | 2 | IPR007527 | |
| Domain | ZF_SWIM | 8.32e-05 | 9 | 29 | 2 | PS50966 | |
| Domain | - | 5.77e-04 | 23 | 29 | 2 | 3.30.530.20 | |
| Domain | START-like_dom | 5.77e-04 | 23 | 29 | 2 | IPR023393 | |
| Domain | - | 4.42e-03 | 64 | 29 | 2 | 3.40.50.1000 | |
| Domain | HAD-like_dom | 6.66e-03 | 79 | 29 | 2 | IPR023214 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 4.20e-13 | 9 | 20 | 5 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.54e-12 | 11 | 20 | 5 | M1091 | |
| Pathway | REACTOME_DIGESTION | 1.11e-10 | 23 | 20 | 5 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 3.22e-10 | 28 | 20 | 5 | M27837 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 8.34e-09 | 52 | 20 | 5 | M14171 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.36e-07 | 8 | 20 | 3 | MM14717 | |
| Pathway | REACTOME_DIGESTION | 3.20e-06 | 21 | 20 | 3 | MM15526 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 5.51e-06 | 25 | 20 | 3 | MM15557 | |
| Pathway | REACTOME_SYNTHESIS_OF_PI | 1.91e-05 | 5 | 20 | 2 | MM14587 | |
| Pathway | REACTOME_SYNTHESIS_OF_PI | 1.91e-05 | 5 | 20 | 2 | M26962 | |
| Pubmed | 2.02e-15 | 6 | 30 | 5 | 2452973 | ||
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 2.02e-15 | 6 | 30 | 5 | 6608795 | |
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 2.02e-15 | 6 | 30 | 5 | 2788608 | |
| Pubmed | 2.02e-15 | 6 | 30 | 5 | 2081604 | ||
| Pubmed | 2.02e-15 | 6 | 30 | 5 | 15286789 | ||
| Pubmed | 1.88e-14 | 8 | 30 | 5 | 12414807 | ||
| Pubmed | 4.50e-13 | 4 | 30 | 4 | 6176715 | ||
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 4.50e-13 | 4 | 30 | 4 | 26132294 | |
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 4.50e-13 | 4 | 30 | 4 | 6162108 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 4.50e-13 | 4 | 30 | 4 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 4.50e-13 | 4 | 30 | 4 | 6166922 | |
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 4.50e-13 | 4 | 30 | 4 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 4.50e-13 | 4 | 30 | 4 | 6163812 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 4.50e-13 | 4 | 30 | 4 | 26098870 | |
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 4.50e-13 | 4 | 30 | 4 | 2431276 | |
| Pubmed | 4.50e-13 | 4 | 30 | 4 | 6160849 | ||
| Pubmed | 4.50e-13 | 4 | 30 | 4 | 16152770 | ||
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 4.50e-13 | 4 | 30 | 4 | 2987507 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 4.50e-13 | 4 | 30 | 4 | 6207174 | |
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 4.50e-13 | 4 | 30 | 4 | 4745489 | |
| Pubmed | 4.50e-13 | 4 | 30 | 4 | 6091898 | ||
| Pubmed | 4.50e-13 | 4 | 30 | 4 | 2423416 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 4.50e-13 | 4 | 30 | 4 | 1141004 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 4.50e-13 | 4 | 30 | 4 | 94264 | |
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 4.50e-13 | 4 | 30 | 4 | 2332419 | |
| Pubmed | 4.50e-13 | 4 | 30 | 4 | 2410924 | ||
| Pubmed | 4.50e-13 | 4 | 30 | 4 | 2476716 | ||
| Pubmed | 4.50e-13 | 4 | 30 | 4 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 4.50e-13 | 4 | 30 | 4 | 3877171 | |
| Pubmed | 4.50e-13 | 4 | 30 | 4 | 3872721 | ||
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 4.50e-13 | 4 | 30 | 4 | 2989529 | |
| Pubmed | 4.50e-13 | 4 | 30 | 4 | 6157477 | ||
| Pubmed | 2.25e-12 | 5 | 30 | 4 | 1348427 | ||
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 2.25e-12 | 5 | 30 | 4 | 8661735 | |
| Pubmed | 2.25e-12 | 5 | 30 | 4 | 6529441 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 2.25e-12 | 5 | 30 | 4 | 34276419 | |
| Pubmed | 2.25e-12 | 5 | 30 | 4 | 6176569 | ||
| Pubmed | 6.74e-12 | 6 | 30 | 4 | 7946325 | ||
| Pubmed | 6.74e-12 | 6 | 30 | 4 | 2002257 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 6.74e-12 | 6 | 30 | 4 | 2328996 | |
| Pubmed | 6.74e-12 | 6 | 30 | 4 | 2450406 | ||
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 6.74e-12 | 6 | 30 | 4 | 284003 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 6.74e-12 | 6 | 30 | 4 | 9250879 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 6.74e-12 | 6 | 30 | 4 | 7859283 | |
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 6.74e-12 | 6 | 30 | 4 | 1021597 | |
| Pubmed | 1.57e-11 | 7 | 30 | 4 | 8666240 | ||
| Pubmed | 1.57e-11 | 7 | 30 | 4 | 7949740 | ||
| Pubmed | 1.57e-11 | 7 | 30 | 4 | 6160178 | ||
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 1.57e-11 | 7 | 30 | 4 | 1401878 | |
| Pubmed | 1.57e-11 | 7 | 30 | 4 | 8604219 | ||
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 1.57e-11 | 7 | 30 | 4 | 2451911 | |
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 3.14e-11 | 8 | 30 | 4 | 7523515 | |
| Pubmed | 3.14e-11 | 8 | 30 | 4 | 2824476 | ||
| Pubmed | 3.14e-11 | 8 | 30 | 4 | 2040456 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 3.14e-11 | 8 | 30 | 4 | 6200103 | |
| Pubmed | 3.14e-11 | 8 | 30 | 4 | 3038891 | ||
| Pubmed | 3.14e-11 | 8 | 30 | 4 | 8486361 | ||
| Pubmed | 5.65e-11 | 9 | 30 | 4 | 93520 | ||
| Pubmed | 9.41e-11 | 10 | 30 | 4 | 9121556 | ||
| Pubmed | 9.41e-11 | 10 | 30 | 4 | 2897103 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 1.48e-10 | 11 | 30 | 4 | 7493641 | |
| Pubmed | 1.48e-10 | 11 | 30 | 4 | 2903254 | ||
| Pubmed | 1.48e-10 | 11 | 30 | 4 | 2565740 | ||
| Pubmed | 1.48e-10 | 11 | 30 | 4 | 23449223 | ||
| Pubmed | Four loci from human chromosome 1 are physically assigned to sheep chromosome 1p. | 1.48e-10 | 11 | 30 | 4 | 8589528 | |
| Pubmed | 1.48e-10 | 11 | 30 | 4 | 7608209 | ||
| Pubmed | 1.48e-10 | 11 | 30 | 4 | 1617215 | ||
| Pubmed | 2.22e-10 | 12 | 30 | 4 | 8144363 | ||
| Pubmed | Assignment of the mouse homologues of 6 loci from HSA1p to chromosomes 3 and 4. | 3.20e-10 | 13 | 30 | 4 | 7829080 | |
| Pubmed | 3.20e-10 | 13 | 30 | 4 | 489953 | ||
| Pubmed | 4.47e-10 | 14 | 30 | 4 | 2902233 | ||
| Pubmed | 4.47e-10 | 14 | 30 | 4 | 7894156 | ||
| Pubmed | Syntenic assignment of human chromosome 1 homologous loci in the bovine. | 4.47e-10 | 14 | 30 | 4 | 8001974 | |
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 30982860 | ||
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 15299664 | ||
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 5.79e-10 | 3 | 30 | 3 | 6360562 | |
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 32697825 | ||
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 22063648 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 5.79e-10 | 3 | 30 | 3 | 2413838 | |
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 6098446 | ||
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 12527308 | ||
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 2414282 | ||
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 5.79e-10 | 3 | 30 | 3 | 2436036 | |
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 1699843 | ||
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 5.79e-10 | 3 | 30 | 3 | 6180955 | |
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 8413315 | ||
| Pubmed | An insulin-responsive element in the pancreatic enhancer of the amylase gene. | 5.79e-10 | 3 | 30 | 3 | 7678001 | |
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 25588701 | ||
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 28659346 | ||
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 6176528 | ||
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 5.79e-10 | 3 | 30 | 3 | 17223109 | |
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 5.79e-10 | 3 | 30 | 3 | 21827821 | |
| Pubmed | 8.12e-10 | 16 | 30 | 4 | 2571572 | ||
| Pubmed | 8.12e-10 | 16 | 30 | 4 | 10842072 | ||
| Pubmed | 1.06e-09 | 17 | 30 | 4 | 25410786 | ||
| Pubmed | 1.36e-09 | 18 | 30 | 4 | 34446743 | ||
| Pubmed | 1.36e-09 | 18 | 30 | 4 | 2338144 | ||
| Pubmed | Gene expression profile of aging and its retardation by caloric restriction. | 1.36e-09 | 57 | 30 | 5 | 10464095 | |
| Pubmed | NEUROD1 reinforces endocrine cell fate acquisition in pancreatic development. | 2.16e-09 | 20 | 30 | 4 | 37689751 | |
| Pubmed | An amylase/Cre transgene marks the whole endoderm but the primordia of liver and ventral pancreas. | 2.32e-09 | 4 | 30 | 3 | 16786601 | |
| Interaction | AMY2B interactions | 3.55e-07 | 10 | 30 | 3 | int:AMY2B | |
| Interaction | HTN3 interactions | 1.18e-05 | 30 | 30 | 3 | int:HTN3 | |
| Cytoband | 1p21 | 3.53e-12 | 24 | 30 | 5 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 8.51e-09 | 107 | 30 | 5 | chr1p21 | |
| GeneFamily | Phosphatidylinositol transfer proteins | 1.10e-05 | 6 | 16 | 2 | 1151 | |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 2.63e-05 | 9 | 16 | 2 | 90 | |
| Coexpression | LEE_AGING_MUSCLE_UP | 1.37e-07 | 41 | 30 | 4 | MM698 | |
| Coexpression | BERGER_MBD2_TARGETS | 2.22e-07 | 11 | 30 | 3 | MM905 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 6.50e-07 | 60 | 30 | 4 | MM654 | |
| Coexpression | IGLESIAS_E2F_TARGETS_DN | 3.88e-06 | 27 | 30 | 3 | MM643 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 5.22e-06 | 399 | 30 | 6 | M41172 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 7.15e-06 | 239 | 30 | 5 | MM1274 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_UP | 9.13e-06 | 116 | 30 | 4 | MM1240 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 1.52e-05 | 132 | 30 | 4 | MM470 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 2.08e-05 | 143 | 30 | 4 | MM1056 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_UP | 3.23e-05 | 54 | 30 | 3 | MM889 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP | 3.74e-05 | 166 | 30 | 4 | MM563 | |
| Coexpression | BORLAK_LIVER_CANCER_EGF_UP | 3.80e-05 | 57 | 30 | 3 | MM527 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 5.70e-05 | 185 | 30 | 4 | MM1072 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN | 7.72e-05 | 200 | 30 | 4 | M6652 | |
| Coexpression | LEIN_MIDBRAIN_MARKERS | 1.39e-04 | 88 | 30 | 3 | MM717 | |
| Coexpression | LIAN_LIPA_TARGETS_6M | 1.86e-04 | 97 | 30 | 3 | MM1016 | |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN | 3.16e-04 | 289 | 30 | 4 | MM1238 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_D_DN | 3.74e-04 | 302 | 30 | 4 | MM1046 | |
| Coexpression | GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_DN | 4.19e-04 | 128 | 30 | 3 | M410 | |
| Coexpression | GSE32901_NAIVE_VS_TH1_CD4_TCELL_UP | 4.49e-04 | 131 | 30 | 3 | M8933 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | 5.22e-04 | 330 | 30 | 4 | MM1120 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-06 | 181 | 30 | 4 | cf8f7798559fedf91ee21b3ebc93171cfd14f89f | |
| ToppCell | droplet-Pancreas-PANCREAS|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-06 | 182 | 30 | 4 | ecb8c1d0b9e0766fae4dd2568456eb78a3cfce9a | |
| ToppCell | droplet-Pancreas-PANCREAS-30m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-06 | 182 | 30 | 4 | cf1ccfc4709364763fa73e60d5f2c05ce268d5c1 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 97 | 30 | 3 | 16947da747504c2edb9f2e7ee6f05babda0fae60 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-05 | 106 | 30 | 3 | 3aa55c3db4e4abd39c8f2f89f2516927d94ad9d7 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-05 | 106 | 30 | 3 | c890c838785dfeda30f3b563194da9cfb49b157a | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.67e-05 | 133 | 30 | 3 | 91e4556658e49f92946d48b194df64c5fc5758fe | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 149 | 30 | 3 | defe2e4a2f3118f8b42e99a4f2bf03e54c1b698f | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 153 | 30 | 3 | 39ac25c48e73538f1c10f37bea386e0e88d3e8d0 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-04 | 159 | 30 | 3 | 2233fee5dcdb6c7dee5b1bd8efbc07d86b339927 | |
| ToppCell | VE-CD8-naive_CD4|VE / Condition, Cell_class and T cell subcluster | 1.67e-04 | 160 | 30 | 3 | 255d2a150bfe19ee3d4d34533feb9c37ce73d225 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 162 | 30 | 3 | 922ecea81063095b8dd9ac9f9792bf551edbb848 | |
| ToppCell | droplet-Pancreas-Exocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 165 | 30 | 3 | c17e00ec9dbe30fcded65a461231dbb13665ddac | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.86e-04 | 166 | 30 | 3 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-04 | 171 | 30 | 3 | 539ea88acc6f948efdeae8b69e5c5ffaee29f1d9 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-04 | 172 | 30 | 3 | 0fc692be845d4225ff8b63bf9195724fc8510c2c | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-04 | 175 | 30 | 3 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-04 | 175 | 30 | 3 | 26bd957498e41a3f1ffa60d3effa27ca8c4ba631 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-04 | 175 | 30 | 3 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-04 | 176 | 30 | 3 | 682a1dfcc507ec540f5fadf08e872533ea9f0291 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-04 | 176 | 30 | 3 | bb41e9478373726eb460af764de0277b2d09928e | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-04 | 176 | 30 | 3 | 9d4a4dfeebb5a8a0f3ab18c37c8ddc2cd2158575 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-04 | 176 | 30 | 3 | ea27e18407b8a13e8212830da859efeb8f158690 | |
| ToppCell | Control-Lymphocyte-T_NK-CD8_TCM|Control / Disease, Lineage and Cell Type | 2.21e-04 | 176 | 30 | 3 | 1a7948eb86ee1da607db4d0576312b2859d94523 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 30 | 3 | 12bccbd56742fcfe19749da802ea1cf62ec9a872 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-04 | 176 | 30 | 3 | bfbab3c5b738b3b0b1540f2059d0245fbd8c0031 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.25e-04 | 177 | 30 | 3 | f1efd9c3074d5635700fe7fbebf3dd0b1e0a84f1 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 178 | 30 | 3 | 415a02ad14df9deba988990118b00fb84ee524a8 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-04 | 179 | 30 | 3 | ecea75c568911ff56939c9f67ab901497bd4356c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-04 | 179 | 30 | 3 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-04 | 179 | 30 | 3 | 5ccf0824611ded5c673d94dff3048aedac12f1a8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.36e-04 | 180 | 30 | 3 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-04 | 180 | 30 | 3 | dcef253f2e97e4436b1b04e8a06a53ff6e64522c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-04 | 181 | 30 | 3 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-04 | 181 | 30 | 3 | a4347ae554e6dcf03c7001a2b69332b377c7c034 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-04 | 182 | 30 | 3 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 183 | 30 | 3 | 99bb4ceb92f6467f2359a42ab2cff6df18825a30 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-04 | 183 | 30 | 3 | 5a541a7f6c3514be8a13e988185dfe388c874f8b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-04 | 183 | 30 | 3 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.56e-04 | 185 | 30 | 3 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.56e-04 | 185 | 30 | 3 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.60e-04 | 186 | 30 | 3 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.64e-04 | 187 | 30 | 3 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.68e-04 | 188 | 30 | 3 | 88b808561ebde997ac8a8bbd1d9bbda49bbb6646 | |
| ToppCell | LPS_only-Lymphocytic_NKT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-04 | 188 | 30 | 3 | bbe65b1c11c88ab62d8485cfc3a913ff9da89aad | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.72e-04 | 189 | 30 | 3 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.77e-04 | 190 | 30 | 3 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-04 | 190 | 30 | 3 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.77e-04 | 190 | 30 | 3 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.81e-04 | 191 | 30 | 3 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.90e-04 | 193 | 30 | 3 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.90e-04 | 193 | 30 | 3 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.90e-04 | 193 | 30 | 3 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.94e-04 | 194 | 30 | 3 | 28c5482da199bcee9e85258a88af453d9fdbd56a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.99e-04 | 195 | 30 | 3 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.99e-04 | 195 | 30 | 3 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 195 | 30 | 3 | cad21edd90bf3e2fefdf5773a59cb1a664a69ddd | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-04 | 195 | 30 | 3 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 | |
| ToppCell | -Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.99e-04 | 195 | 30 | 3 | e5b0afbea85575851cf9eb50a9ac42c67bbf3d7c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-04 | 196 | 30 | 3 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-04 | 196 | 30 | 3 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-04 | 197 | 30 | 3 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-04 | 197 | 30 | 3 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-04 | 197 | 30 | 3 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature2_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.12e-04 | 198 | 30 | 3 | 89e25687b614525548279e5fa293c66f5c4abec3 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 3.12e-04 | 198 | 30 | 3 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | LPS_IL1RA-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.17e-04 | 199 | 30 | 3 | 9382abe4ca553bc4db12e413be921b626e56f2ac | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.17e-04 | 199 | 30 | 3 | 618dc6425bb7b84d3b2de7cf8ecb41549a255718 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.17e-04 | 199 | 30 | 3 | 46e2d2962cd5b0f76baf976c0f6ecce117827274 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-04 | 200 | 30 | 3 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-04 | 200 | 30 | 3 | 3cbb01039d1e7635ec4dcdf0223587f7ea3c7b34 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-04 | 200 | 30 | 3 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-04 | 200 | 30 | 3 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-CD4+_T_naive|Int-URO / Disease, condition lineage and cell class | 3.22e-04 | 200 | 30 | 3 | a4b531355e87efd6b69a16eeec8b1ff14c7af750 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-04 | 200 | 30 | 3 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-04 | 200 | 30 | 3 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-04 | 200 | 30 | 3 | 97a010a1b6d551239cf6ea5a43319fb413ff180e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-04 | 200 | 30 | 3 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-04 | 200 | 30 | 3 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-04 | 200 | 30 | 3 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-04 | 200 | 30 | 3 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-04 | 200 | 30 | 3 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Kidney-Fibroblasts|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 3.22e-04 | 200 | 30 | 3 | 2c265ad8314a21bce50ac21b16da2fea125366ea | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-04 | 200 | 30 | 3 | 8ccf2dbbe34b26fbf2bbef1e64b4ae636edd6672 | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-04 | 200 | 30 | 3 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-04 | 200 | 30 | 3 | 320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c | |
| Drug | R 623 | 1.68e-14 | 6 | 30 | 5 | CID003027594 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 1.68e-14 | 6 | 30 | 5 | CID003083414 | |
| Drug | CNP-G3 | 1.68e-14 | 6 | 30 | 5 | CID003082910 | |
| Drug | dimethylaminomethylferrocene | 1.68e-14 | 6 | 30 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 1.68e-14 | 6 | 30 | 5 | CID000127364 | |
| Drug | BG5P | 5.86e-14 | 7 | 30 | 5 | CID003082752 | |
| Drug | AC1L5BOU | 5.86e-14 | 7 | 30 | 5 | CID000174858 | |
| Drug | desethylaprophen | 1.56e-13 | 8 | 30 | 5 | CID000163919 | |
| Drug | azintamide | 1.56e-13 | 8 | 30 | 5 | CID000071105 | |
| Drug | alpha-maltosyl fluoride | 3.51e-13 | 9 | 30 | 5 | CID000194237 | |
| Drug | trestatin A | 3.51e-13 | 9 | 30 | 5 | CID003054994 | |
| Drug | AC1LAC07 | 7.01e-13 | 10 | 30 | 5 | CID000485275 | |
| Drug | AC1L3M0Q | 7.01e-13 | 10 | 30 | 5 | CID000118008 | |
| Drug | Ro 20-0083 | 7.01e-13 | 10 | 30 | 5 | CID003082332 | |
| Drug | Glc)4 | 7.01e-13 | 10 | 30 | 5 | CID000189098 | |
| Drug | 2C KM | 1.28e-12 | 11 | 30 | 5 | CID009549196 | |
| Drug | validamycin D | 1.28e-12 | 11 | 30 | 5 | CID000166726 | |
| Drug | FG5P | 1.28e-12 | 11 | 30 | 5 | CID000127486 | |
| Drug | CNP-G5 | 1.28e-12 | 11 | 30 | 5 | CID000127309 | |
| Drug | HgI2 | 1.28e-12 | 11 | 30 | 5 | CID000024485 | |
| Drug | azaprophen | 2.20e-12 | 12 | 30 | 5 | CID000129486 | |
| Drug | beta-santalene | 2.45e-12 | 4 | 30 | 4 | CID000010534 | |
| Drug | 2-nitropropyl acetate | 2.45e-12 | 4 | 30 | 4 | CID013573844 | |
| Drug | N-PMT | 2.45e-12 | 4 | 30 | 4 | CID000194224 | |
| Drug | SAIB-SG | 2.45e-12 | 4 | 30 | 4 | CID002735139 | |
| Drug | Dembrexine | 2.45e-12 | 4 | 30 | 4 | CID000072009 | |
| Drug | g lw | 2.45e-12 | 4 | 30 | 4 | CID000444139 | |
| Drug | AC1MQT4V | 2.45e-12 | 4 | 30 | 4 | CID003482066 | |
| Drug | methyl 1'-epiacarviosin | 3.57e-12 | 13 | 30 | 5 | CID000197426 | |
| Drug | isoacarbose | 3.57e-12 | 13 | 30 | 5 | CID000449165 | |
| Drug | Cyclodextrins | 5.55e-12 | 14 | 30 | 5 | CID000024238 | |
| Drug | terephthaloyl chloride | 5.55e-12 | 14 | 30 | 5 | CID000007488 | |
| Drug | 2-chloro-4-nitrophenol | 5.55e-12 | 14 | 30 | 5 | CID000012074 | |
| Drug | 4-nitrophenylmaltoheptaoside | 8.32e-12 | 15 | 30 | 5 | CID000173254 | |
| Drug | gamma-cyclodextrin | 1.21e-11 | 16 | 30 | 5 | CID000086575 | |
| Drug | Bay e 4609 | 1.21e-11 | 16 | 30 | 5 | CID003085308 | |
| Drug | cimicifugic acid A | 1.22e-11 | 5 | 30 | 4 | CID006449879 | |
| Drug | silver perchlorate | 1.22e-11 | 5 | 30 | 4 | CID000024562 | |
| Drug | lunularic acid | 1.22e-11 | 5 | 30 | 4 | CID000161413 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 1.22e-11 | 5 | 30 | 4 | CID010358258 | |
| Drug | actinidine | 1.22e-11 | 5 | 30 | 4 | CID000068231 | |
| Drug | himachalene | 1.22e-11 | 5 | 30 | 4 | CID000015095 | |
| Drug | 2TAA | 1.22e-11 | 5 | 30 | 4 | CID000127374 | |
| Drug | Deposiston | 1.22e-11 | 5 | 30 | 4 | CID003080829 | |
| Drug | AC1L4DZ4 | 1.22e-11 | 5 | 30 | 4 | CID000155287 | |
| Drug | trimitan | 2.37e-11 | 18 | 30 | 5 | CID000005561 | |
| Drug | aprophen | 2.37e-11 | 18 | 30 | 5 | CID000071128 | |
| Drug | vermella | 3.67e-11 | 6 | 30 | 4 | CID000203726 | |
| Drug | Gu-4 | 3.67e-11 | 6 | 30 | 4 | CID000448679 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 3.67e-11 | 6 | 30 | 4 | CID009577343 | |
| Drug | Borane dimethylamine complex | 3.67e-11 | 6 | 30 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 3.67e-11 | 6 | 30 | 4 | CID000092801 | |
| Drug | 2-amino-6-picoline | 3.67e-11 | 6 | 30 | 4 | CID000015765 | |
| Drug | hymenin | 3.67e-11 | 6 | 30 | 4 | CID000010499 | |
| Drug | phenol blue | 3.67e-11 | 6 | 30 | 4 | CID000075078 | |
| Drug | AC1OAGH8 | 3.67e-11 | 6 | 30 | 4 | CID006857368 | |
| Drug | mercuric thiocyanate | 3.67e-11 | 6 | 30 | 4 | CID000011615 | |
| Drug | AC1L3XPY | 5.61e-11 | 21 | 30 | 5 | CID000124005 | |
| Drug | maltosaccharide | 7.25e-11 | 22 | 30 | 5 | CID005461034 | |
| Drug | Paramax | 8.55e-11 | 7 | 30 | 4 | CID000156411 | |
| Drug | 3KBG5CNP | 8.55e-11 | 7 | 30 | 4 | CID003083250 | |
| Drug | AC1L9UU3 | 8.55e-11 | 7 | 30 | 4 | CID000071762 | |
| Drug | methyl blue | 8.55e-11 | 7 | 30 | 4 | CID011969534 | |
| Drug | amino-methyl | 8.55e-11 | 7 | 30 | 4 | CID000142005 | |
| Drug | Panose B | 1.17e-10 | 24 | 30 | 5 | CID000439297 | |
| Drug | CID439354 | 1.46e-10 | 25 | 30 | 5 | CID000439354 | |
| Drug | 9-azidoacridine | 1.71e-10 | 8 | 30 | 4 | CID000146692 | |
| Drug | acrinor | 1.71e-10 | 8 | 30 | 4 | CID005489637 | |
| Drug | boric acid gel | 1.71e-10 | 8 | 30 | 4 | CID003016474 | |
| Drug | AC1NSVJM | 1.71e-10 | 8 | 30 | 4 | CID005317411 | |
| Drug | theodrenaline | 1.71e-10 | 8 | 30 | 4 | CID000071857 | |
| Drug | rhodanile blue | 1.71e-10 | 8 | 30 | 4 | CID000073372 | |
| Drug | N-vinylcaprolactam | 1.71e-10 | 8 | 30 | 4 | CID000075227 | |
| Drug | NSC300622 | 1.71e-10 | 8 | 30 | 4 | CID000028426 | |
| Drug | Atonik | 3.07e-10 | 9 | 30 | 4 | CID000069471 | |
| Drug | GU-3 | 3.07e-10 | 9 | 30 | 4 | CID000448687 | |
| Drug | GSAD | 3.07e-10 | 9 | 30 | 4 | CID009909127 | |
| Drug | zingiberene | 3.07e-10 | 9 | 30 | 4 | CID000092776 | |
| Drug | mercuric nitrate | 3.07e-10 | 9 | 30 | 4 | CID000024864 | |
| Drug | H 187 | 3.07e-10 | 9 | 30 | 4 | CID000001742 | |
| Drug | N-bromosuccinimide | 3.48e-10 | 69 | 30 | 6 | CID000067184 | |
| Drug | N,N'-disalicylidene-1,3-diaminopropane | 3.89e-10 | 30 | 30 | 5 | CID005373003 | |
| Drug | eicosa-11,14-dienoic acid | 5.11e-10 | 10 | 30 | 4 | CID000003208 | |
| Drug | trans-cinnamamide | 5.11e-10 | 10 | 30 | 4 | CID000012135 | |
| Drug | CG-120 | 5.11e-10 | 10 | 30 | 4 | CID000171403 | |
| Drug | I ZE | 5.11e-10 | 10 | 30 | 4 | CID009549200 | |
| Drug | UDP-pyridoxal | 5.11e-10 | 10 | 30 | 4 | CID000126789 | |
| Drug | naphthalene-1,3,6,8-tetrol | 5.11e-10 | 10 | 30 | 4 | CID000440202 | |
| Drug | Folin Marenzi reagent | 5.49e-10 | 32 | 30 | 5 | CID000452313 | |
| Drug | R625 | 6.47e-10 | 33 | 30 | 5 | CID000072375 | |
| Drug | AMO-1618 | 8.03e-10 | 11 | 30 | 4 | CID000017103 | |
| Drug | AC1L8PXO | 8.03e-10 | 11 | 30 | 4 | CID000430710 | |
| Drug | Tempamine | 8.03e-10 | 11 | 30 | 4 | CID000550942 | |
| Drug | L-tert-leucine | 8.03e-10 | 11 | 30 | 4 | CID000164608 | |
| Drug | PNPC | 8.83e-10 | 35 | 30 | 5 | CID000165125 | |
| Drug | BCDs | 1.18e-09 | 37 | 30 | 5 | CID000364214 | |
| Drug | 3-hydr-oxy-2-naphthohydrazide | 1.20e-09 | 12 | 30 | 4 | CID000072699 | |
| Drug | H2folate | 1.20e-09 | 12 | 30 | 4 | CID000168809 | |
| Drug | AC1L4W0B | 1.20e-09 | 12 | 30 | 4 | CID000193311 | |
| Drug | chloroisocyanuric acid | 1.20e-09 | 12 | 30 | 4 | CID000017921 | |
| Disease | alpha-amylase 1 measurement | 9.44e-11 | 9 | 29 | 4 | EFO_0801371 | |
| Disease | calcium measurement | 3.16e-03 | 628 | 29 | 4 | EFO_0004838 | |
| Disease | body composition measurement | 1.54e-02 | 193 | 29 | 2 | EFO_0005106 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WHQRDRGTMWKVHFV | 466 | P51690 | |
| FWRVMMRVCWLVRQD | 11 | Q7Z2E3 | |
| DWVCEHRWRQIRNMV | 396 | P0DTE7 | |
| DWVCEHRWRQIRNMV | 396 | P0DTE8 | |
| DWVCEHRWRQIRNMV | 396 | P0DUB6 | |
| DWVCEHRWRQIRNMV | 396 | P19961 | |
| DWVCEHRWRQIRNMV | 396 | P04746 | |
| MYCERIRRKFWPEWH | 321 | Q5TGI0 | |
| VWDCAMVRHVAWLIF | 766 | Q9HBX8 | |
| ATAHRRRWWMACTAV | 6 | Q8N370 | |
| DRIRTWFWTKWVRMR | 1856 | A6NKB5 | |
| VTVFSRQHMRWLWDI | 2091 | Q5H8C1 | |
| LRRVMVRAHRQAWCW | 216 | Q9BZ72 | |
| MFAPTKTWRRWHRRV | 101 | P36578 | |
| SWVRMWCVRQRYCRL | 76 | A8MTL0 | |
| RLQDWRCLWCKAMVH | 261 | Q16760 | |
| VFNRIWKMLSEIWHR | 276 | Q8NHV1 | |
| RRVMLRAHRQAWCWQ | 216 | O00562 | |
| WMDGVLHCAVRAWRA | 106 | Q5SV17 | |
| WMHKRIWHRVSCNSV | 776 | Q92618 | |
| RSHYVDWRMWRDVKR | 26 | O60783 | |
| NWRRREMVRWLVTCA | 881 | Q9P217 | |
| LMWRFIHSQLRHWRE | 306 | Q15035 | |
| RHVQWLMGKLRFRWR | 166 | Q86SX3 | |
| WSCTLWMIRNRRKYA | 526 | Q9H5I5 | |
| SGMRHVWRKVDTVWV | 456 | Q9BV44 | |
| NWRRREMVRWLVTCA | 911 | Q9HCJ5 | |
| RVWWMFRVFGHRTVS | 111 | Q16762 | |
| WHRRRILMGKIFRTW | 151 | Q9H0E7 | |
| WRRRHWAVKMVTCFI | 321 | Q9UBN4 |